Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure

Abstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation...

Full description

Bibliographic Details
Main Authors: Tetsuma Kawaji, Satoshi Shizuta, Takanori Aizawa, Shintaro Yamagami, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Kimura
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13160
id doaj-0a7fd11155f24889bc493bc778ecdbec
record_format Article
spelling doaj-0a7fd11155f24889bc493bc778ecdbec2021-03-31T03:15:45ZengWileyESC Heart Failure2055-58222021-02-018167067910.1002/ehf2.13160Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failureTetsuma Kawaji0Satoshi Shizuta1Takanori Aizawa2Shintaro Yamagami3Masashi Kato4Takafumi Yokomatsu5Shinji Miki6Koh Ono7Takeshi Kimura8Department of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine Tenri Hospital Tenri JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanAbstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation for AF who had coexisting HF, which was defined as prior HF hospitalization, estimated right ventricular systolic pressure ≥45 mmHg, or B‐type natriuretic peptide (BNP) ≥200 pg/dL before the procedure. The primary endpoints were improvements in left ventricular ejection fraction (LVEF), E/e′, BNP, left atrial dimension (LAD), and mitral regurgitation (MR) at 1 year. The secondary endpoints were serial changes of LVEF, E/e′, BNP, LAD, and MR at 6 months, 1 year, and 5 years and cumulative incidence of HF hospitalization. During the mean follow‐up of 5.1 ± 3.0 years, 70.7% of patients were free from recurrent AF. Among patients with LVEF < 50%, E/e′ ≥ 15, BNP ≥ 200 pg/dL, LAD ≥ 40 mm, and moderate‐to‐severe MR, changes in those parameters from baseline to 1 year were 34.5 ± 9.9% to 43.2 ± 14.4% (P < 0.001), 19.7 ± 3.9 to 12.5 ± 6.6 (P < 0.001), 290 to 85 pg/dL (P < 0.001), and 100% to 37.8% (P < 0.001), respectively. The improvements in the cardiac disorders were maintained up to 5 years except for E/e′. In patients with LVEF < 40%, significant delayed improvement of LVEF beyond 1 year was observed (ΔLVEF = 10.5 ± 18.5, P = 0.001), but not in patients with LVEF of 40–49%. The cumulative incidence of HF hospitalization was 12.6% at 5 years. Baseline diastolic dysfunction was the only independent predictor for subsequent HF hospitalization. Conclusions In patients undergoing AF ablation with coexisting HF, all cardiac disorders significantly improved after the procedure, which was mostly maintained during 5 year follow‐up.https://doi.org/10.1002/ehf2.13160Atrial fibrillationCatheter ablationHeart failureSystolic dysfunctionDiastolic dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author Tetsuma Kawaji
Satoshi Shizuta
Takanori Aizawa
Shintaro Yamagami
Masashi Kato
Takafumi Yokomatsu
Shinji Miki
Koh Ono
Takeshi Kimura
spellingShingle Tetsuma Kawaji
Satoshi Shizuta
Takanori Aizawa
Shintaro Yamagami
Masashi Kato
Takafumi Yokomatsu
Shinji Miki
Koh Ono
Takeshi Kimura
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
ESC Heart Failure
Atrial fibrillation
Catheter ablation
Heart failure
Systolic dysfunction
Diastolic dysfunction
author_facet Tetsuma Kawaji
Satoshi Shizuta
Takanori Aizawa
Shintaro Yamagami
Masashi Kato
Takafumi Yokomatsu
Shinji Miki
Koh Ono
Takeshi Kimura
author_sort Tetsuma Kawaji
title Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
title_short Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
title_full Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
title_fullStr Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
title_full_unstemmed Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
title_sort impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
publisher Wiley
series ESC Heart Failure
issn 2055-5822
publishDate 2021-02-01
description Abstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation for AF who had coexisting HF, which was defined as prior HF hospitalization, estimated right ventricular systolic pressure ≥45 mmHg, or B‐type natriuretic peptide (BNP) ≥200 pg/dL before the procedure. The primary endpoints were improvements in left ventricular ejection fraction (LVEF), E/e′, BNP, left atrial dimension (LAD), and mitral regurgitation (MR) at 1 year. The secondary endpoints were serial changes of LVEF, E/e′, BNP, LAD, and MR at 6 months, 1 year, and 5 years and cumulative incidence of HF hospitalization. During the mean follow‐up of 5.1 ± 3.0 years, 70.7% of patients were free from recurrent AF. Among patients with LVEF < 50%, E/e′ ≥ 15, BNP ≥ 200 pg/dL, LAD ≥ 40 mm, and moderate‐to‐severe MR, changes in those parameters from baseline to 1 year were 34.5 ± 9.9% to 43.2 ± 14.4% (P < 0.001), 19.7 ± 3.9 to 12.5 ± 6.6 (P < 0.001), 290 to 85 pg/dL (P < 0.001), and 100% to 37.8% (P < 0.001), respectively. The improvements in the cardiac disorders were maintained up to 5 years except for E/e′. In patients with LVEF < 40%, significant delayed improvement of LVEF beyond 1 year was observed (ΔLVEF = 10.5 ± 18.5, P = 0.001), but not in patients with LVEF of 40–49%. The cumulative incidence of HF hospitalization was 12.6% at 5 years. Baseline diastolic dysfunction was the only independent predictor for subsequent HF hospitalization. Conclusions In patients undergoing AF ablation with coexisting HF, all cardiac disorders significantly improved after the procedure, which was mostly maintained during 5 year follow‐up.
topic Atrial fibrillation
Catheter ablation
Heart failure
Systolic dysfunction
Diastolic dysfunction
url https://doi.org/10.1002/ehf2.13160
work_keys_str_mv AT tetsumakawaji impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT satoshishizuta impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT takanoriaizawa impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT shintaroyamagami impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT masashikato impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT takafumiyokomatsu impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT shinjimiki impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT kohono impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
AT takeshikimura impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure
_version_ 1724178606404403200